Israel will stop licensing doctors from medical schools it doesn't recognize

Israel will restrict its physician licensing exam, starting in 2026, to graduates of medical schools accredited by the World Federation for Medical Education — a change known as the Yatziv reform, after Prof. Shaul Yatziv, who led the government investigation that produced it [s1].

Why the investigation happened

In 2019, Israel's Ministry of Health opened an investigation into the quality of training at foreign medical schools after reports surfaced questioning the medical competence of some foreign-trained physicians [s1]. Yatziv's investigation found that certain schools — concentrated in non-OECD countries — didn't meet academic standards and didn't provide adequate clinical exposure during training [s1]. That finding is the direct basis for the policy: rather than evaluating individual graduates case by case, Israel is now gating licensing eligibility at the institutional level, using WFME accreditation as the bar.

Who's actually affected, and when it started

The reform doesn't apply retroactively to everyone already licensed or already enrolled before it took effect — it specifically targets students who enrolled from 2019 onward at schools that lack WFME accreditation, mostly in non-OECD countries [s1]. That 2019 cutoff means the reform was signaled years before its 2026 implementation, giving prospective students a warning window, even if many may not have known about it when choosing where to enroll.

The scale of the projected impact

By one projection, 32% of Israelis graduating from medical school abroad in 2025 will be graduates of universities that don't meet WFME recognition standards [s1] — meaning roughly a third of that graduating cohort could face licensing exclusion under the new rule once it takes effect. That's a large enough share that the reform isn't a narrow technical fix affecting a handful of edge cases; it's a policy that reshapes a meaningful pipeline into the Israeli physician workforce.

The equity dimension the reform's critics point to

The reform is projected to disproportionately affect Arab professionals in Israel, since a large share have historically studied at institutions that fall outside WFME recognition [s1]. That creates a genuine tension the available reporting doesn't resolve: a policy justified on training-quality grounds, applied at the institutional rather than individual level, can produce a disparate impact on a specific population even without that being its stated intent. Whether the quality concerns that motivated the reform are distributed evenly across the affected schools, or concentrated in ways that would have supported a narrower policy, isn't something this reporting establishes either way.

What this doesn't settle

The available reporting documents the reform's design and its projected demographic impact, but doesn't report how Israel plans to address the physician workforce gap this could create if a meaningful share of previously eligible foreign-trained graduates are now excluded — Israel, like many countries, already faces physician shortage pressures separate from this reform.

What to watch next

Whether Israel pairs this licensing restriction with expanded domestic medical school capacity or other workforce measures to offset the pipeline it's narrowing, and how the reform's actual 2026 implementation — as opposed to its 2019-dated projection — plays out for the cohort of students who enrolled abroad in the years since the policy was signaled.